COVID-19 pandemic-altered epidemiology of pediatric infectious diseases and vasculitis: A single-center observational study
Corresponding Author
Ryuichi Nakagawa
Department of Pediatrics, Musashino Red Cross Hospital, Musashino, Japan
Correspondence
Ryuichi Nakagawa, Department of Pediatrics, Musashino Red Cross Hospital, 1-26-1, Kyonan-cho Musashino-city, Tokyo 180-8610, Japan.
Email: [email protected]
Search for more papers by this authorMari Okada
Department of Pediatrics, Musashino Red Cross Hospital, Musashino, Japan
Search for more papers by this authorSayuri Hashimoto
Department of Pediatrics, Musashino Red Cross Hospital, Musashino, Japan
Search for more papers by this authorHaruna Yokoyama
Department of Pediatrics, Musashino Red Cross Hospital, Musashino, Japan
Search for more papers by this authorTeruyoshi Shimoyama
Department of Pediatrics, Musashino Red Cross Hospital, Musashino, Japan
Search for more papers by this authorTomohiro Udagawa
Department of Pediatrics, Musashino Red Cross Hospital, Musashino, Japan
Search for more papers by this authorAkihiro Oshiba
Department of Pediatrics, Musashino Red Cross Hospital, Musashino, Japan
Search for more papers by this authorMasayuki Nagasawa
Department of Pediatrics, Musashino Red Cross Hospital, Musashino, Japan
Search for more papers by this authorCorresponding Author
Ryuichi Nakagawa
Department of Pediatrics, Musashino Red Cross Hospital, Musashino, Japan
Correspondence
Ryuichi Nakagawa, Department of Pediatrics, Musashino Red Cross Hospital, 1-26-1, Kyonan-cho Musashino-city, Tokyo 180-8610, Japan.
Email: [email protected]
Search for more papers by this authorMari Okada
Department of Pediatrics, Musashino Red Cross Hospital, Musashino, Japan
Search for more papers by this authorSayuri Hashimoto
Department of Pediatrics, Musashino Red Cross Hospital, Musashino, Japan
Search for more papers by this authorHaruna Yokoyama
Department of Pediatrics, Musashino Red Cross Hospital, Musashino, Japan
Search for more papers by this authorTeruyoshi Shimoyama
Department of Pediatrics, Musashino Red Cross Hospital, Musashino, Japan
Search for more papers by this authorTomohiro Udagawa
Department of Pediatrics, Musashino Red Cross Hospital, Musashino, Japan
Search for more papers by this authorAkihiro Oshiba
Department of Pediatrics, Musashino Red Cross Hospital, Musashino, Japan
Search for more papers by this authorMasayuki Nagasawa
Department of Pediatrics, Musashino Red Cross Hospital, Musashino, Japan
Search for more papers by this author
CONFLICT OF INTEREST STATEMENT
We have nothing to declare.
Open Research
DATA AVAILABILITY STATEMENT
Data are available on request from the authors.
REFERENCES
- 1Hwang HH, Lim IS, Choi BS, Yi DY. Analysis of seasonal tendencies in pediatric Henoch-Schönlein purpura and comparison with outbreak of infectious diseases. Medicine. 2018; 97(36):e12217. doi:10.1097/MD.0000000000012217
- 2Ohtsuka T, Yamazaki S. Prevalence of human parvovirus B19 component NS1 gene in patients with Henoch-Schonlein purpura and hypersensitivity vasculitis. Br J Dermatol. 2005; 152(5): 1080-1081. doi:10.1111/j.1365-2133.2005.06566.x
- 3Nagao Y, Urabe C, Nakamura H, Hatano N. Predicting the characteristics of the aetiological agent for Kawasaki disease from other paediatric infectious diseases in Japan. Epidemiol Infect. 2016; 144(3): 478-492. doi:10.1017/S0950268815001223
- 4Huang SH, Chen CY, Weng KP, et al. Adenovirus infection and subsequent risk of Kawasaki disease: a population-based cohort study. J Chin Med Assoc. 2020; 83(3): 302-306. doi:10.1097/JCMA.0000000000000266
- 5https://idsc.tmiph.metro.tokyo.lg.jp/weekly/.
- 6Ayusawa M, Sonobe T, Uemura S, et al. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int off J Jpn Pediatr Soc. 2005; 47(2): 232-234. doi:10.1111/j.1442-200x.2005.02033.x
- 7Kobayashi T, Ayusawa M, Suzuki H, et al. Revision of diagnostic guidelines for Kawasaki disease (6th revised edition). Pediatr Int off J Jpn Pediatr Soc. 2020; 62(10): 1135-1138. doi:10.1111/ped.14326
- 8Kobayashi T, Inoue Y, Takeuchi K, et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation. 2006; 113(22): 2606-2612. doi:10.1161/CIRCULATIONAHA.105.592865
- 9Mills JA, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum. 1990; 33(8): 1114-1121. doi:10.1002/art.1780330809
- 10Hong SJ, Kang B, Hwang JH, et al. The occurrence of infection-related systemic diseases in Korean children and adolescents has decreased after the spread of the COVID-19 pandemic: a multicenter retrospective study. Transl Pediatr. 2021; 10(11): 2888-2896. doi:10.21037/tp-21-315
- 11Yang YL, Kuo HC. Public health interventions for COVID-19 reduce Kawasaki disease in Taiwan. Child Basel Switz. 2021; 8(8):623. doi:10.3390/children8080623
- 12Ae R, Shibata Y, Kosami K, Nakamura Y, Hamada H. Kawasaki disease and pediatric infectious diseases during the coronavirus disease 2019 pandemic. J Pediatr. 2021; 239: 50-58.e2. doi:10.1016/j.jpeds.2021.07.053
- 13Kaya Akca U, Atalay E, Cuceoglu MK, et al. Impact of the COVID-19 pandemic on the frequency of the pediatric rheumatic diseases. Rheumatol Int. 2022; 42(1): 51-57. doi:10.1007/s00296-021-05027-7
Citing Literature
